MedPath

Can a peer support program for women with an altered cancer gene reduce distress?

Not Applicable
Completed
Conditions
Psychosocial effects of testing positive for a mutation of the BRCA1/2 gene
Cancer - Ovarian and primary peritoneal
Mental Health - Anxiety
Cancer - Breast
Registration Number
ACTRN12608000343303
Lead Sponsor
The Cancer Council Victoria
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
337
Inclusion Criteria

Women testing positive for the BRCA1/2 gene fault between 2004 and 2011. Women may participate if they have had a diagnosis of cancer.

Exclusion Criteria

A diagnosis of advanced/metastatic cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Distress measured by the Impact of Events Scale[Baseline, then at 4-months and 6-months post-randomisation]
Secondary Outcome Measures
NameTimeMethod
Social isolation, measured by a modified version of the UCLA Loneliness Scale[Baseline, then at 4-months and 6-months post-randomisation]
© Copyright 2025. All Rights Reserved by MedPath